Search tips
Search criteria 


Logo of archdischArchives of Disease in ChildhoodVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
Arch Dis Child. 1972 October; 47(255): 766–771.
PMCID: PMC1648214

Coagulation Studies in Haemolytic Uraemic Syndrome


Serial coagulation investigations were performed in 4 children with the haemolytic uraemic syndrome treated with heparin by continuous infusion. 2 anuric patients showed consumption of factor V and fibrinogen early in the disease, with thrombocytopenia and raised fibrin degradation products. These changes regressed during heparin therapy and renal function fully recovered in both patients. A third patient with a mild form of the disease, normal urinary output, and only borderline thrombocytopenia did not develop demonstrable depletion of factor V or fibrinogen. In a further patient a secondary `wave' of consumption of platelets and perhaps fibrinogen was seen late in the course of the disease. These findings confirmed the occurrence of a consumptive coagulopathy in severe cases of haemolytic uraemic syndrome.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (787K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • ALKJAERSIG N, FLETCHER AP, SHERRY S. xi-Aminocaproic acid: an inhibitor of plasminogen activation. J Biol Chem. 1959 Apr;234(4):832–837. [PubMed]
  • Baker LR, Rubenberg ML, Dacie JV, Brain MC. Fibrinogen catabolism in microangiopathic haemolytic anaemia. Br J Haematol. 1968 Jun;14(6):617–625. [PubMed]
  • Brain MC. The haemolytic-uraemic syndrome. Semin Hematol. 1969 Apr;6(2):162–180. [PubMed]
  • Brain MC, Baker LR, McBride JA, Rubenberg ML, Dacie JV. Treatment of patients with microangiopathic haemolytic anaemia with heparin. Br J Haematol. 1968 Dec;15(6):603–621. [PubMed]
  • BRAIN MC, DACIE JV, HOURIHANE DO. Microangiopathic haemolytic anaemia: the possible role of vascular lesions in pathogenesis. Br J Haematol. 1962 Oct;8:358–374. [PubMed]
  • Brain MC, Hourihane DO. Microangiopathic haemolytic anaemia: the occurrence of haemolysis in experimentally produced vascular disease. Br J Haematol. 1967 Jan;13(1):135–142. [PubMed]
  • BRECHER G, CRONKITE EP. Morphology and enumeration of human blood platelets. J Appl Physiol. 1950 Dec;3(6):365–377. [PubMed]
  • Bull BS, Rubenberg ML, Dacie JV, Brain MC. Microangiopathic haemolytic anaemia: mechanisms of red-cell fragmentation: in vitro studies. Br J Haematol. 1968 Jun;14(6):643–652. [PubMed]
  • Corrigan JJ, Jr, Ray WL, May N. Changes in the blood coagulation system associated with septicemia. N Engl J Med. 1968 Oct 17;279(16):851–856. [PubMed]
  • Deykin D. The clinical challenge of disseminated intravascular coagulation. N Engl J Med. 1970 Sep 17;283(12):636–644. [PubMed]
  • Gilchrist GS, Lieberman E, Ekert H, Fine RN, Grushkin C. Heparin therapy in the haemolytic-uraemic syndrome. Lancet. 1969 Jun 7;1(7606):1123–1126. [PubMed]
  • Hammond D, Lieberman E. The hemolytic uremic syndrome. Renal cortical thrombotic microangiopathy. Arch Intern Med. 1970 Nov;126(5):816–822. [PubMed]
  • HARDISTY RM, MACPHERSON JC. A one-stage factor VIII (antihaemophilic globulin) assay and its use on venous and capillary plasma. Thromb Diath Haemorrh. 1962 May 15;7:215–228. [PubMed]
  • Hathaway WE. Care of the critically ill child: the problem of disseminated intravascular coagulation. Pediatrics. 1970 Nov;46(5):767–773. [PubMed]
  • Hitzig WH, Straub PW, Lo SS, Frick PG. Disseminated intravascular coagulation. Clinical experience with anticoagulant therapy in the management of disseminated intravascular coagulation in children. Proc R Soc Med. 1968 Nov;61(11 Pt 1):1138–1138. [PubMed]
  • Katz J, Lurie A, Kaplan BS, Krawitz S, Metz J. Coagulation findings in the hemolytic-uremic syndrome of infancy: similarity to hyperacute renal allograft rejection. J Pediatr. 1971 Mar;78(3):426–434. [PubMed]
  • Lanzkowsky P, McCrory W. Disseminated intravascular coagulation as a possible factor in the pathogenesis of thrombotic microangiopathy (hemolytic-uremic syndrome). J Pediatr. 1967 Mar;70(3):460–462. [PubMed]
  • Merskey C, Kleiner GJ, Johnson AJ. Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment. Blood. 1966 Jul;28(1):1–18. [PubMed]
  • Moncrieff MW, Glasgow EF. Haemolytic-uraemic syndrome treated with heparin. Br Med J. 1970 Jul 25;3(5716):188–191. [PMC free article] [PubMed]
  • Monnens L, Schretlen E. Intravascular coagulation in an infant with the hemolytic-uremic syndrome. Acta Paediatr Scand. 1967 Jul;56(4):436–441. [PubMed]
  • Rubenberg ML, Regoeczi E, Bull BS, Dacie JV, Brain MC. Microangiopathic haemolytic anaemia: the experimental production of haemolysis and red-cell fragmentation by defibrination in vivo. Br J Haematol. 1968 Jun;14(6):627–642. [PubMed]
  • Avalos JS, Vitacco M, Molinas F, Peñalver J, Gianantonio C. Coagulation studies in the hemolytic-uremic syndrome. J Pediatr. 1970 Apr;76(4):538–548. [PubMed]
  • Sharpstone P, Evans RG, O'Shea M, Alexander L, Lee HA. Haemolytic-uraemic syndrome: survival after prolonged oliguria. Arch Dis Child. 1968 Dec;43(232):711–716. [PMC free article] [PubMed]
  • STEFANINI M. New one-stage procedures for the quantitative determination of prothrombin and labile factor. Am J Clin Pathol. 1950 Mar;20(3):233–240. [PubMed]
  • Uttley WS. Serum levels of fibrin-fibrinogen degradation products in the haemolytic-uraemic syndrome. Arch Dis Child. 1970 Aug;45(242):587–589. [PMC free article] [PubMed]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group